Cargando…
Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
Immune activation is associated with increased risk of tuberculosis (TB) disease in infants. We performed a case-control analysis to identify drivers of immune activation and disease risk. Among 49 infants who developed TB disease over the first 2 years of life, and 129 healthy matched controls, we...
Autores principales: | Müller, Julius, Tanner, Rachel, Matsumiya, Magali, Snowden, Margaret A., Landry, Bernard, Satti, Iman, Harris, Stephanie A., O’Shea, Matthew K., Stockdale, Lisa, Marsay, Leanne, Chomka, Agnieszka, Harrington-Kandt, Rachel, Thomas, Zita-Rose Manjaly, Naranbhai, Vivek, Stylianou, Elena, Mbandi, Stanley Kimbung, Hatherill, Mark, Hussey, Gregory, Mahomed, Hassan, Tameris, Michele, McClain, J. Bruce, Evans, Thomas G., Hanekom, Willem A., Scriba, Thomas J., McShane, Helen, Fletcher, Helen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962026/ https://www.ncbi.nlm.nih.gov/pubmed/31697647 http://dx.doi.org/10.1172/jci.insight.130090 |
Ejemplares similares
-
Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants
por: Fletcher, Helen A., et al.
Publicado: (2016) -
T-cell activation is an immune correlate of risk in BCG vaccinated infants
por: Fletcher, Helen A., et al.
Publicado: (2016) -
Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014) -
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
por: Matsumiya, Magali, et al.
Publicado: (2014) -
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
por: Tameris, Michele D, et al.
Publicado: (2013)